{"text": ["Novartis", "(NVS)", "Receives", "FDA", "Approval", "for", "MS", "Drug", "Mayzent"], "created_at": "2019-03-27 22:13:10"}
{"text": ["Jazz's", "Xyrem", "Follow-On", "Drug", "Succeeds", "in", "Phase", "III", "Study"], "created_at": "2019-03-27 22:07:15"}
{"text": ["Jazz's", "Xyrem", "Follow-On", "Drug", "Succeeds", "in", "Phase", "III", "Study"], "created_at": "2019-03-27 22:07:15"}
{"text": ["Jazz's", "Xyrem", "Follow-On", "Drug", "Succeeds", "in", "Phase", "III", "Study"], "created_at": "2019-03-27 20:30:08"}
{"text": ["The", "Hits", "Just", "Keep", "Coming", "For", "Biogen", "As", "Rival", "Gains", "MS", "Drug", "Approval"], "created_at": "2019-03-27 20:12:14"}
{"text": ["Novartis", "MS", "drug", "wins", "FDA's", "blessing", "amid", "scrutiny", "of", "$88k", "annual", "price"], "created_at": "2019-03-27 17:19:00"}
{"text": ["6", "Gene", "Therapy", "M&A", "Targets", "On", "The", "Radar"], "created_at": "2019-03-27 16:45:40"}
{"text": ["Novartis", "Multiple", "Sclerosis", "Drug", "With", "Price", "Tag", "of", "$88,000", "Gets", "FDA", "Nod"], "created_at": "2019-03-27 15:15:00"}
{"text": ["FDA", "Approves", "Novartis", "Drug", "To", "Treat", "More", "Severe", "Form", "Of", "Multiple", "Sclerosis"], "created_at": "2019-03-27 13:15:58"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "FDA", "Nod", "For", "Novartis,", "Jazz", "Positive", "Late-Stage", "Data", "For", "Sleep", "Disorder", "Drug,", "Genfit", "IPO"], "created_at": "2019-03-27 11:52:54"}
{"text": ["Novartis", "new", "MS", "drug", "Mayzent", "to", "be", "priced", "at", "$88,000", "per", "year"], "created_at": "2019-03-27 07:33:38"}
{"text": ["Novartis", "gets", "U.S.", "approval", "for", "new", "drug", "to", "treat", "multiple", "sclerosis"], "created_at": "2019-03-27 06:57:01"}
